Receptor Occupancy

Overview

Receptor occupancy (RO) is the fraction of a receptor population engaged by a ligand at a given time. It is the bridge between pharmacokinetics (drug concentration) and pharmacodynamics (biological response). Most peptide and small-molecule therapies aim for a particular receptor occupancy range over a chosen duration — higher or lower than this range and the therapy is ineffective, redundant, or toxic.

Detailed Explanation

Basic equation

For a simple, single-site ligand:

RO = [L] / (Kd + [L])

where Kd is the dissociation constant. This is a rectangular hyperbola that asymptotically approaches 100% occupancy at high ligand concentration. Specific landmarks:

• [L] = Kd → 50% occupancy
• [L] = 9 × Kd → 90% occupancy
• [L] = 99 × Kd → 99% occupancy

Pushing from 90% to 99% occupancy requires roughly a 10-fold concentration increase, meaning receptor saturation has diminishing returns for added exposure.

Occupancy vs. effect

Maximum response and maximum occupancy are not the same thing. In systems with receptor reserve ("spare receptors"), the full tissue response may be produced at occupancies well below 100%. This produces an EC50 that is considerably lower than Kd.

Conversely, in systems without spare receptors, 50% effect requires roughly 50% occupancy, so EC50 ≈ Kd.

Partial agonists reach their Emax with full occupancy, but that Emax is below 100% of the system's maximum — see partial agonist.

Time integration

Instantaneous occupancy is useful but often secondary to the time-integrated occupancy. If a drug produces brief 90% occupancy but falls quickly, total effect may be less than a drug giving sustained 50% occupancy. Area under the receptor-occupancy-time curve is the more relevant metric for many peptide therapeutics.

Receptor reserve

Many tissues express more receptors than strictly needed to produce maximal response. Antagonist studies using irreversible inhibitors can quantify reserve — the fraction of receptors that can be eliminated while still producing full response. High reserve systems tolerate partial blockade or low occupancy better than systems with tight coupling.

Measurement

Imaging

Positron emission tomography (PET) with labeled peptides or small molecules directly measures RO in living subjects. Receptor occupancy studies are widely used in:

• Neuropsychiatry (D2 receptor occupancy by antipsychotics)
• Oncology (PARP, CDK4/6 occupancy by targeted drugs)
• Peptide therapeutics (somatostatin receptor imaging with PET tracers)

Ex vivo

Radioligand displacement assays on tissue homogenates quantify occupancy at sacrifice.

Functional proxies

In clinical studies, pharmacodynamic biomarkers are often used as surrogates for RO. For GLP-1 analogs, changes in C-peptide secretion or glucose-insulin dynamics substitute for direct occupancy measurement.

Factors Shaping Occupancy

• Free ligand concentration — not total, since plasma protein binding sequesters drug
• Receptor number — varies with tissue, disease, and receptor trafficking
• Competing endogenous ligands — a high-tone endogenous agonist reduces occupancy achievable by an exogenous competitor
• Residence time — slow koff maintains occupancy even as plasma drug falls
• Internalization and recycling — receptors sequestered internally are invisible to extracellular ligand

Relevance to Peptide Therapeutics

Peptide design and dosing decisions are often guided by target RO windows:

• GLP-1 analogs — aim for sustained high RO in pancreatic β-cells and hypothalamic neurons
• Growth hormone secretagogues — pulsatile high RO rather than continuous full saturation, to preserve pulsatility and avoid tachyphylaxis
• Somatostatin analogs — sustained high RO for therapy, transient high RO for imaging
• Melanocortin agonists — moderate RO sufficient for therapeutic effect, higher RO risks adverse events

Receptor Occupancy and Adverse Effects

Side effects often correlate with RO at off-target receptors. A peptide that achieves 80% RO at its target but also 30% RO at a related subtype will inevitably produce off-target consequences. Improving selectivity shifts the concentration-occupancy curve at the target vs. off-target, widening the therapeutic window.

Summary

Receptor occupancy is the fraction of receptors bound at a moment in time — the quantitative bridge between pharmacokinetics and pharmacodynamics. Understanding and measuring RO across dose ranges, durations, and tissues is the backbone of rational peptide dosing, biomarker selection, and clinical development.